All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

BiondVax Pharmaceuticals Ltd. revenue reports

BiondVax Pharmaceuticals Ltd. financial reports, BiondVax Pharmaceuticals Ltd. annual revenue in 2024. When does BiondVax Pharmaceuticals Ltd. report revenue?
Add to widgets
Added to widgets

BiondVax Pharmaceuticals Ltd. total revenue, net income and dynamics of changes in US dollar today

BiondVax Pharmaceuticals Ltd. revenue for the past few reporting periods. Net revenue BiondVax Pharmaceuticals Ltd. is now 0 $. Information about net revenue is taken from open sources. The dynamics of BiondVax Pharmaceuticals Ltd. net income rose by 5 911 000 $. The assessment of the dynamics of BiondVax Pharmaceuticals Ltd. net income was made in comparison with the previous report. Schedule of the financial report of BiondVax Pharmaceuticals Ltd. for today. The financial report on the chart of BiondVax Pharmaceuticals Ltd. allows you to clearly see the dynamics of fixed assets. A graph of the value of all BiondVax Pharmaceuticals Ltd. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 0 $ - -8 186 000 $ -1546.29 % ↓
31/12/2020 0 $ - -14 097 000 $ -
30/09/2020 0 $ - 55 315 000 $ -
30/06/2020 0 $ - -41 978 000 $ -
30/09/2019 0 $ - -19 355 000 $ -
30/06/2019 0 $ - -47 389 000 $ -
31/03/2019 0 $ - 566 000 $ -
31/12/2018 0 $ - -36 490 000 $ -
30/09/2018 0 $ - -6 724 000 $ -
30/06/2018 0 $ - -30 311 000 $ -
31/03/2018 0 $ - -14 202 000 $ -
31/12/2017 0 $ - -3 549 365.30 $ -
30/09/2017 0 $ - 368 801.12 $ -
30/06/2017 0 $ - -3 344 028 $ -
Show:
to

BiondVax Pharmaceuticals Ltd. financial report charts

The latest dates of BiondVax Pharmaceuticals Ltd. financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of BiondVax Pharmaceuticals Ltd. is 31/03/2021. Operating income BiondVax Pharmaceuticals Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income BiondVax Pharmaceuticals Ltd. is -6 755 000 $

BiondVax Pharmaceuticals Ltd. quarterly report dates

Net income BiondVax Pharmaceuticals Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income BiondVax Pharmaceuticals Ltd. is -8 186 000 $ Current assets BiondVax Pharmaceuticals Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets BiondVax Pharmaceuticals Ltd. is 49 058 000 $ Total assets BiondVax Pharmaceuticals Ltd. refers to the total amount of assets owned by a person or entity. Total assets BiondVax Pharmaceuticals Ltd. is 94 724 000 $

Current cash BiondVax Pharmaceuticals Ltd. - the sum of all of the cash a company has on the date of report. Current cash BiondVax Pharmaceuticals Ltd. is 48 577 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
- - - - - - - - - - - - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- - - - - - - - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
- - - - - - - - - - - - - -
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-6 755 000 $ -12 133 000 $ 55 603 000 $ -16 087 000 $ -18 923 000 $ -19 690 000 $ -7 165 000 $ -27 966 000 $ -5 822 000 $ -30 650 000 $ -12 629 000 $ -4 278 494.03 $ -908 558.40 $ -742 321.50 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-8 186 000 $ -14 097 000 $ 55 315 000 $ -41 978 000 $ -19 355 000 $ -47 389 000 $ 566 000 $ -36 490 000 $ -6 724 000 $ -30 311 000 $ -14 202 000 $ -3 549 365.30 $ 368 801.12 $ -3 344 028 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 750 000 $ 7 868 000 $ 12 579 000 $ 11 948 000 $ 16 133 000 $ 15 172 000 $ 5 732 000 $ 26 616 000 $ 4 347 000 $ 29 205 000 $ 11 745 000 $ 3 939 364.39 $ 332 288.96 $ 579 303 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
6 755 000 $ 12 133 000 $ -55 603 000 $ 16 087 000 $ 18 923 000 $ 19 690 000 $ 7 165 000 $ 27 966 000 $ 5 822 000 $ 30 650 000 $ 12 629 000 $ 4 278 494.03 $ 908 558.40 $ 742 321.50 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
49 058 000 $ 10 625 000 $ 27 704 000 $ 41 219 000 $ 77 134 000 $ 35 174 000 $ 59 386 000 $ 76 848 000 $ 55 701 000 $ 41 195 000 $ 58 650 000 $ 21 642 506.39 $ 23 172 767.84 $ 11 291 824.50 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
94 724 000 $ 56 911 000 $ 74 917 000 $ 85 709 000 $ 119 336 000 $ 75 769 000 $ 99 359 000 $ 105 837 000 $ 80 764 000 $ 60 868 000 $ 72 067 000 $ 23 478 979.61 $ 23 688 749.76 $ 11 789 761.50 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
48 577 000 $ 9 421 000 $ 24 774 000 $ 38 752 000 $ 75 247 000 $ 33 916 000 $ 57 532 000 $ 75 883 000 $ 52 985 000 $ 37 128 000 $ 55 675 000 $ 20 515 044.04 $ 21 763 511.68 $ 8 977 191 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 3 069 000 $ 10 011 000 $ 17 200 000 $ 21 799 000 $ 2 713 000 $ 2 103 000 $ 9 294 000 $ - - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - - 20 515 044.04 $ 21 763 511.68 $ 10 142 386.50 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 139 769 000 $ 148 282 000 $ 129 950 000 $ 137 052 000 $ 75 547 000 $ 44 157 000 $ 29 939 000 $ - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 117.12 % 195.70 % 130.79 % 129.49 % 93.54 % 72.55 % 41.54 % - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
20 804 000 $ -14 596 000 $ -1 841 000 $ -61 922 000 $ -20 433 000 $ -72 513 000 $ -30 591 000 $ -31 215 000 $ 5 217 000 $ 16 711 000 $ 42 128 000 $ 16 166 712.30 $ 19 430 129.92 $ 6 013 348.50 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -24 926 000 $ -24 926 000 $ -13 228 000 $ -6 452 000 $ -3 186 000 $ -38 502 000 $ -9 053 000 $ -227 906.61 $ -1 086 024.48 $ -873 538.50 $

Last revenue report of BiondVax Pharmaceuticals Ltd. was 31/03/2021. According to last financial report total revenue in BiondVax Pharmaceuticals Ltd. was 0 US dollar and changed by 0% since last year. Net income in BiondVax Pharmaceuticals Ltd. was -8 186 000 $ in last quartal, net income changes to -1546.29%.

BiondVax Pharmaceuticals Ltd. stocks data

BiondVax Pharmaceuticals Ltd. financials